These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24970337)

  • 1. Percutaneous or surgical revascularization in multivessel coronary artery disease: synthesis from SYNTAX.
    Taggart DP
    Eur Heart J; 2014 Oct; 35(40):2789-91. PubMed ID: 24970337
    [No Abstract]   [Full Text] [Related]  

  • 2. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.
    Taggart DP
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):978-9. PubMed ID: 24047712
    [No Abstract]   [Full Text] [Related]  

  • 3. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
    J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid coronary revascularization for treatment of multivessel coronary artery disease.
    Hu S
    Eur Heart J; 2014 Oct; 35(38):2624-5. PubMed ID: 25422839
    [No Abstract]   [Full Text] [Related]  

  • 6. Calculating risks and benefits to help guide revascularization decisions: turning all available data into useful information.
    Harrington RA
    J Am Coll Cardiol; 2014 Aug; 64(5):433-5. PubMed ID: 25082574
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: Toward Patient-Centric Decision Making.
    Bangalore S; Ali ZA; Stone GW
    JAMA Cardiol; 2019 Jun; 4(6):507-508. PubMed ID: 31017619
    [No Abstract]   [Full Text] [Related]  

  • 8. The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
    Glineur D; Gaudino M; Grau J
    Circulation; 2016 Oct; 134(17):1206-1208. PubMed ID: 27777289
    [No Abstract]   [Full Text] [Related]  

  • 9. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease.
    Gössl M; Faxon DP; Bell MR; Holmes DR; Gersh BJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):597-604. PubMed ID: 22896575
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat?
    Stefanini GG; Windecker S; Kolh P
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):406-7. PubMed ID: 25312531
    [No Abstract]   [Full Text] [Related]  

  • 13. Developments in surgical revascularization to achieve improved morbidity and mortality.
    Sepehripour AH; Athanasiou T
    Expert Rev Cardiovasc Ther; 2016; 14(3):367-79. PubMed ID: 26589373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE.
    Leacche M; Byrne JG; Solenkova NS; Reagan B; Mohamed TI; Fredi JL; Zhao DX
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):1004-1012. PubMed ID: 22541514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease.
    Spinthakis N; Farag M; Gorog DA; Prasad A; Mahmood H; Gue Y; Wellsted D; Nabhan A; Srinivasan M
    Int J Cardiol; 2017 Dec; 249():101-106. PubMed ID: 28958756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
    Khan AR; Golwala H; Tripathi A; Riaz H; Kumar A; Flaherty MP; Bhatt DL
    Am J Cardiol; 2017 Jun; 119(12):1949-1956. PubMed ID: 28442067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How is the heart best protected in chronic dialysis patients?: Between Scylla and Charybdis: what is the appropriate role for percutaneous coronary revascularization and coronary artery bypass grafting in patients on dialysis?
    Charytan DM
    Semin Dial; 2014; 27(4):325-8. PubMed ID: 24438072
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.